Considering that miR‐375 can preserve MNs from DNA damage‐induced apoptosis via inhibition of p53 and given its down‐regulation in ALS carrying the FUS mutation,71 miR‐375 can represent an interesting therapeutic target. Here, TP53 is linked to amyotrophic lateral sclerosis.